PRIME II breast cancer trial.

PRIME II breast cancer trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

PRIME II breast cancer trial. Abstract Text:

PRIME II breast cancer trial. Publishing Authors By Initials

For similar investigative techniques: epidemiologic methods: statistics as topic: survival analysis research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: survival analysis research

PUBMED ID PMID:

MEDLINE DATE:

PRIME II breast cancer trial. Journal Published:

PUBLICATION TYPE: Editorial

Journal: Clinical oncology (Royal College of Radiologists (

VOLUME: 16

Page Numbers: 447-8

Journal Abbreviation: Clin Oncol (R Coll Radiol)

ISSN: 0936-6555

DAY: 10

MONTH: Oct

YEAR: 2004

PRIME II breast cancer trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9002902

PRIME II breast cancer trial. Keywords Mesh Terms:

KEYWORDS: Survival Analysis

MESH TERMS: prevention & control

Chemical & Substance for Abstract: PRIME II breast cancer trial. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for PRIME II breast cancer trial.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Oncol (R Coll Radiol)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

PRIME II breast cancer trial Related Publications

• Carcinoma of the male breast metastatic to the mandible.
• Controversies in the management of metastatic spinal cord compression.
• Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
• Impact of Breast Radiotherapy on Quality of Life in Older Patients: A Phase III Trial.
• Locoregional treatment in breast cancer: new paradigm raises new questions.
• PRIME II breast cancer trial.
• The Barthel Index in assessing the response to palliative radiotherapy in malignant spinal cord compression: a prospective audit.
• The use of single fraction Leksell stereotactic radiosurgery in the treatment of uveal melanoma.
• [Not Available.]